ATProto Browser

Record data

{
  "uri": "at://did:plc:672lt7wfql3ukdbcm467bcxt/app.bsky.feed.post/3looq5ck32c2y",
  "cid": "bafyreig4kzowyvztairqak7klkqbnxlsqzgtoastr3bqohugiwqnm53bcm",
  "value": {
    "text": "www.openpr.com/news/4006639...",
    "$type": "app.bsky.feed.post",
    "embed": {
      "$type": "app.bsky.embed.external",
      "external": {
        "uri": "https://www.openpr.com/news/4006639/nontuberculous-mycobacterial-infections-clinical-trials",
        "thumb": {
          "$type": "blob",
          "ref": {
            "$link": "bafkreidriey4qp4prpcx636h5v6yex32ovh5bqvtu6vgh2jt7nzrcsy4aa"
          },
          "mimeType": "image/jpeg",
          "size": 919122
        },
        "title": "Nontuberculous Mycobacterial Infections Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, NICE Approval, IND, ROA, MOA, NDA Approval and Companies involved by DelveInsight",
        "description": "Albany United States As per DelveInsight s assessment globally Nontuberculous Mycobacterial Infections pipeline constitutes 10 key companies continuously working towards developing 10 Nontuberculous M..."
      }
    },
    "langs": [
      "en"
    ],
    "facets": [
      {
        "index": {
          "byteEnd": 30,
          "byteStart": 0
        },
        "features": [
          {
            "uri": "https://www.openpr.com/news/4006639/nontuberculous-mycobacterial-infections-clinical-trials",
            "$type": "app.bsky.richtext.facet#link"
          }
        ]
      }
    ],
    "createdAt": "2025-05-08T20:16:31.571Z"
  }
}